MigraineArchives
Targeting glial-orchestrated neuroinflammation in migraine pathophysiology
Migraine 13 min.
Migraine is a prevalent, disabling neurological disorder with prominent sensory and neurovascular features that substantially impairs quality of life and societal productivity [1, 2]. According to the Global Burden of Disease Study, migraine affects approximately 1 billion people worldwide [3], with...
Prospective open-label trial of personalised connectivity-guided transcranial magnetic stimulation therapy for migraine
Migraine 6 min.
Migraine is characterised by recurrent moderate-to-severe headaches, affecting 1 billion people globally and ranks as the second leading cause of disability [1, 2]. In addition to medications, repetitive transcranial magnetic stimulation (rTMS) has emerged as...
Altered serum short-chain fatty acid profiles in episodic and chronic migraine and their modulation by preventive treatment
Migraine 7 min.
Migraine affects more than one billion people worldwide and imposes a substantial burden on individuals’ daily functioning and quality of life [1, 2]. Migraine ranks as the second leading cause of disability worldwide, particularly among individuals of working age, thereby contributing to a significant...
Factors contributing to inaccurate migraine diagnosis: a prospective study at a tertiary hospital in Southern Thailand
Migraine 4 min.
Migraine is one of the most prevalent and disabling neurological disorders worldwide, affecting approximately 17.9% of women and 10.6% of men [1]. It ranks among the top five causes of years lived with disability (YLDs) globally, with a particularly high burden during the most productive years of life...
